Pharmacometrics Archives

On-Demand Webinar

Master clinical phase transitions with insights from industry leaders! Join Piet van der Graaf, SVP…

CertaraJanuary 2, 2024

Press Coverage

Published: December 21, 2023 This is the article written in German, published on pharmind. Children's…

CertaraDecember 21, 2023

Case Study

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Case Study

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

CertaraMay 9, 2023

Case Study

Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…

CertaraJanuary 23, 2023

Case Study

Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…

CertaraJune 1, 2022

Case Study

RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…

CertaraNovember 17, 2021

Pharmacometrics